FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns gastroenterology and represents a composition for treatment of pancreatic insufficiency containing microbial lipase, microbial protease and microbial amylase, and the ratio of lipase, protease and amylase in the specified composition makes approximately 1:1:0.15 USP units.
EFFECT: invention provides preparation of stable compositions with pancreatic enzymes, exhibiting maximum efficiency with minimum dosages and characterised with a common safety profile.
31 cl, 3 ex, 10 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS OF PANCREATIC ENZYMES AND METHOD OF TREATING PANCREATITIS AND PANCREAS INSUFFICIENCY | 2010 |
|
RU2570376C2 |
METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS | 2013 |
|
RU2654230C2 |
STABLE COMPOSITIONS OF DIGESTIVE ENZYMES | 2008 |
|
RU2445952C2 |
COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION | 2014 |
|
RU2651458C2 |
METHOD FOR DISSOLUTION TESTING OF SOLID COMPOSITIONS CONTAINING DIGESTIVE ENZYMES | 2012 |
|
RU2602183C2 |
ENZYMES FOR PHARMACEUTICAL APPLICATION | 2005 |
|
RU2389504C2 |
DRUG FOR TREATING DIABETES CASES | 2000 |
|
RU2268065C2 |
PROTEASES FOR PHARMACEUTICAL APPLICATION | 2006 |
|
RU2420578C2 |
DIGESTIVE AGENT OF MICROBIAL ENZYMES | 2009 |
|
RU2429291C1 |
HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2686460C2 |
Authors
Dates
2010-04-10—Published
2005-10-14—Filed